Theophylline Tablet, Extended Release
Product Images NDC 51407-319

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 51407-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-318-01ol.jpg (51407 318 01ol)

The text describes the packaging details of Theophylline Extended-Release Tablets made by GSMS Incorporated. This medicine comes in a pack of 100 tablets, with each tablet containing 400mg of anhydrous Theophylline for oral administration. The recommended dose is available in the package insert. The pack should be stored in an environment with controlled room temperature complying with USP. The rest of the text comprises random characters and is non-readable.*

FDA Label Image

51407-319-01lb.jpg (51407 319 01lb)

This is a description of a medication for Theophylline (Anhydrous) extended-release tablets manufactured by Nostrum Laboratories that provides 600mg of the medication and are packaged by GSMS, Incorporated. The medication should be kept tightly closed in a light-resistant container and kept away from children. The packaging includes a warning to keep medicines out of reach of children. The package insert containing important information should be consulted before use.*

FDA Label Image

Theophylline Structural Formula (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.